The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial.

Laura A BonouvriéJules G BecherJohan S H VlesR Jeroen VermeulenAnnemieke I Buizernull null

Published in: Annals of neurology (2019)

Intrathecal baclofen treatment is superior to placebo in achieving treatment goals in patients with severe dyskinetic cerebral palsy. ANN NEUROL 2019.

Keyphrases

cerebral palsy
clinical trial
study protocol
randomized controlled trial
phase iii
public health
combination therapy
phase ii
open label
drug induced